AstraZeneca PLC

AZN

GB0009895292

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 08:46:55 2024-04-25 am EDT			5-day change	1st Jan Change
11,945 ^GBX	+5.22%		+9.18%	+12.42%

02:33pm	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Data	MT
02:25pm	ASTRAZENECA : Jefferies sticks Neutral	ZD

ASTRAZENECA : Barclays reiterates its Buy rating

July 18, 2022 at 07:28 am EDT

Barclays analyst Emily Field maintains his Buy rating on the stock. The target price remains set at GBX 12000.

Latest news about AstraZeneca PLC

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Data	08:33am	MT
ASTRAZENECA : Jefferies sticks Neutral	08:25am	ZD
ASTRAZENECA : JP Morgan remains its Buy rating	08:15am	ZD
FTSE 100 hits high on offer for Anglo American	06:52am	AN
AstraZeneca Q1 Core Earnings, Revenue Increase -- Shares Jump Premarket	06:31am	MT
ANALYST RECOMMENDATIONS : Meta Platforms, UPS, Boeing, Chipotle, Dell Technologies...	05:58am
AstraZeneca Earnings, Sales Rise, Beating Forecasts -- Update	05:43am	DJ
European Midday Briefing : Mood Cautious Ahead of More U.S Tech, Key Data	05:20am	DJ
London rises ahead of US GDP data	04:56am
AstraZeneca: strong sales growth in Q1	04:34am	CF
AstraZeneca upbeat as cancer drugs underpin sales growth	04:20am	AN
Anglo American jumps on takeover bid from BHP	04:14am	AN
FTSE 100 hits record high on big mining M&A, earnings push	03:24am	RE
Miner Anglo American reviews takeover bid from rival BHP	02:58am	AN
Miner Anglo American eyes rival BHP takeover	02:44am	AN
AstraZeneca Earnings, Sales Rise, Beat Forecasts	02:37am	DJ
AstraZeneca Reports Growth in Q1 Attributable Profit, Total Revenue	02:30am	MT
Earnings Flash (AZN.L) ASTRAZENECA Posts Q1 EPS $1.40	02:13am	MT
AstraZeneca beats first-quarter revenue, profit estimates	02:06am	RE
AstraZeneca PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	02:00am	CI
Stocks called down ahead of US GDP data	01:50am	AN
Sanofi Q1 profit slips on generic competition, forex effects	01:30am	RE
MORNING BID EUROPE-Gearing up for the tech roller-coaster ride	12:31am	RE
EMEA Morning Briefing : Shares Seen Lower; Earnings, U.S. GDP Data in Focus	12:16am	DJ
No record close for FTSE 100; mixed trade in US	Apr. 24	AN

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

Pharmaceuticals

Calendar

02:00am - Q1 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR) , FTSE 100

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ASTRAZENECA : AstraZeneca should not be overlooked for long

April 03, 2024 at 10:26 am EDT

More Strategies

Ratings for AstraZeneca PLC

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

141.1 USD

Average target price

161.4 USD

Spread / Average Target

+14.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ASTRAZENECA PLC	+12.42%	219B
ELI LILLY AND COMPANY	+25.61%	660B
NOVO NORDISK A/S	+22.89%	562B
JOHNSON & JOHNSON	-5.24%	358B
MERCK & CO., INC.	+16.49%	322B
ABBVIE INC.	+8.28%	297B
ROCHE HOLDING AG	-9.94%	196B
NOVARTIS AG	+6.49%	199B
PFIZER, INC.	-8.75%	149B
AMGEN INC.	-5.21%	146B

Other Pharmaceuticals

AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

ASTRAZENECA : Barclays reiterates its Buy rating

Latest news about AstraZeneca PLC

Chart AstraZeneca PLC

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for AstraZeneca PLC

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals